UBS Group’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-164,000
Closed -$5.58M 9757
2023
Q3
$5.58M Buy
164,000
+14,000
+9% +$529K ﹤0.01% 2470
2023
Q2
$5.9M Buy
150,000
+80,000
+114% +$2.89M ﹤0.01% 2422
2023
Q1
$2.25M Hold
70,000
﹤0.01% 3294
2022
Q4
$2.18M Buy
+70,000
New +$2.53M ﹤0.01% 3311

Other funds holding PGNY

UBS Group's PGNY Position: Q1 2026 in Review

UBS Group increased its Progyny (PGNY) stake by 190% in Q1 2026, buying an estimated $5.26M and bringing the position to 374,444 shares worth $6.36M. The position accounts for ﹤0.01% of the portfolio, ranked #3810.

UBS Group first reported a position in PGNY in Q4 2019 and has held it in 26 quarters since. The position peaked at $6.6M in Q3 2024. 291 funds tracked by Wall St. Rank hold PGNY as of Q1 2026.

  • UBS Group held 374,444 shares of Progyny worth $6.36M as of Q1 2026.
  • UBS Group bought 245,357 Progyny shares in Q1 2026, an estimated $5.26M.
  • Progyny made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3810 holding.
  • UBS Group first reported a position in Progyny in Q4 2019 and has held it in 26 quarters since.
  • UBS Group's Progyny position peaked at $6.6M in Q3 2024.
  • 291 funds tracked by Wall St. Rank held Progyny as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.